这个股票炒什么内的？_老虎社区_美港股上老虎

形态市值热点
2020-07-24

这个股票炒什么内的？走势这么强？是干细胞技术突破了吗？

$Brainstorm Cell Therapuetics Inc(BCLI)$Brainstorm Cell Therapeutics$(BCLI)$ 生物技术公司董事Sankesh Abbhi增持46,779股，每股12.99美元，总价607659美元。 EVP和首席运营官David Setboun增持5000股，每股12.95美元，总价64740美元。中性偏多策略，考虑此股年底前不太可能低于12

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":946072159,"tweetId":"946072159","gmtCreate":1595548900771,"gmtModify":1704209384937,"author":{"id":3558142396072078,"idStr":"3558142396072078","authorId":3558142396072078,"authorIdStr":"3558142396072078","name":"形态市值热点","avatar":"https://static.tigerbbs.com/fcaaf06d05fe983d2233baa873942d5c","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":20,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body>\n这个股票炒什么内的？走势这么强？是干细胞技术突破了吗？</body></html>","htmlText":"<html><head></head><body>\n这个股票炒什么内的？走势这么强？是干细胞技术突破了吗？</body></html>","text":"这个股票炒什么内的？走势这么强？是干细胞技术突破了吗？","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/946072159","repostId":948694055,"repostType":1,"repost":{"magic":2,"id":948694055,"tweetId":"948694055","gmtCreate":1595340137977,"gmtModify":1704208618150,"author":{"id":3439778424152374,"idStr":"3439778424152374","authorId":3439778424152374,"authorIdStr":"3439778424152374","name":"hedgefund888","avatar":"https://static.tigerbbs.com/32c46c16b05f197541a984dabe4e820b","vip":2,"userType":2,"introduction":"私募操盘手，期权量化策略，风控第一，拒绝价值投资拥抱对冲投机","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":7796,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><a href=\"https://laohu8.com/S/BCLI\">$Brainstorm Cell Therapuetics Inc(BCLI)$</a>Brainstorm Cell Therapeutics$(BCLI)$生物技术公司董事Sankesh Abbhi增持46,779股，每股12.99美元，总价607659美元。EVP和首席运营官David Setboun增持5000股，每股12.95美元，总价64740美元。中性偏多策略，考虑此股年底前不太可能低于12</body></html>","htmlText":"<html><head></head><body><a href=\"https://laohu8.com/S/BCLI\">$Brainstorm Cell Therapuetics Inc(BCLI)$</a>Brainstorm Cell Therapeutics$(BCLI)$生物技术公司董事Sankesh Abbhi增持46,779股，每股12.99美元，总价607659美元。EVP和首席运营官David Setboun增持5000股，每股12.95美元，总价64740美元。中性偏多策略，考虑此股年底前不太可能低于12</body></html>","text":"$Brainstorm Cell Therapuetics Inc(BCLI)$Brainstorm Cell Therapeutics$(BCLI)$ 生物技术公司 董事Sankesh Abbhi增持46,779股，每股12.99美元，总价607659美元。 EVP和首席运营官David Setboun增持5000股，每股12.95美元，总价64740美元。 中性偏多策略，考虑此股年底前不太可能低于12","highlighted":1,"essential":1,"paper":1,"link":"https://laohu8.com/post/948694055","repostId":0,"isVote":1,"tweetType":1,"commentLimit":10,"symbols":["BCLI"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":248,"xxTargetLangEnum":"ZH_CN"},"isVote":1,"tweetType":1,"viewCount":1801,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":51,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}